Loading...
MDxHealth S.A.
MDXH•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.49
$0.05(2.05%)
MDxHealth S.A. (MDXH) Financial Performance & Income Statement Overview
Review MDxHealth S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
28.29%
↑ 28.29%
Operating Income Growth
9.53%
↑ 9.53%
Net Income Growth
11.67%
↑ 11.67%
Operating Cash Flow Growth
13.80%
↑ 13.80%
Operating Margin
-24.03%
↓ 24.03%
Gross Margin
61.99%
↑ 61.99%
Net Profit Margin
-41.02%
↓ 41.02%
ROE
-534.88%
↓ 534.88%
ROIC
-17.24%
↓ 17.24%
MDxHealth S.A. (MDXH) Income Statement & Financial Overview
Review MDxHealth S.A.'s (MDXH) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $24.74M | $23.32M | $22.16M | $19.83M |
Cost of Revenue | $9.22M | $9.04M | $8.87M | $8.90M |
Gross Profit | $15.52M | $14.28M | $13.29M | $10.94M |
Gross Profit Ratio | $0.63 | $0.61 | $0.60 | $0.55 |
R&D Expenses | $2.79M | $2.70M | $2.90M | $2.16M |
SG&A Expenses | $15.57M | $16.35M | $16.48M | $15.39M |
Operating Expenses | $20.13M | $20.37M | $20.70M | $17.55M |
Total Costs & Expenses | $29.35M | $29.41M | $29.58M | $26.45M |
Interest Income | $0.00 | $197000.00 | $222000.00 | $1.91M |
Interest Expense | $0.00 | $4.96M | $1.39M | $1.91M |
Depreciation & Amortization | $2.19M | $2.15M | $1.80M | $1.90M |
EBITDA | -$2.42M | -$3.75M | -$5.62M | -$4.70M |
EBITDA Ratio | -$0.10 | -$0.16 | -$0.25 | -$0.24 |
Operating Income | -$4.61M | -$6.09M | -$7.42M | -$6.61M |
Operating Income Ratio | -$0.19 | -$0.26 | -$0.33 | -$0.33 |
Other Income/Expenses (Net) | -$2.19M | -$4.76M | -$4.11M | -$1.91M |
Income Before Tax | -$6.79M | -$10.86M | -$11.53M | -$8.51M |
Income Before Tax Ratio | -$0.27 | -$0.47 | -$0.52 | -$0.43 |
Income Tax Expense | $48000.00 | $334000.00 | $0.00 | $1.86M |
Net Income | -$6.84M | -$11.19M | -$11.53M | -$8.51M |
Net Income Ratio | -$0.28 | -$0.48 | -$0.52 | -$0.43 |
EPS | -$0.14 | -$0.40 | -$0.42 | -$0.31 |
Diluted EPS | -$0.14 | -$0.24 | -$0.42 | -$0.31 |
Weighted Avg Shares Outstanding | $48.86M | $27.97M | $27.29M | $27.29M |
Weighted Avg Shares Outstanding (Diluted) | $48.86M | $47.29M | $27.29M | $27.29M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan